These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12173017)

  • 1. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
    Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
    Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
    Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
    Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
    Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
    J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
    Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B
    Orv Hetil; 2002 Nov; 143(47):2631-6. PubMed ID: 12532649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.
    Gulyás B; Vas A; Halldin C; Sóvágó J; Sandell J; Olsson H; Fredriksson A; Stone-Elander S; Farde L
    Nucl Med Biol; 2002 Oct; 29(7):753-9. PubMed ID: 12381455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöck P; Paróczai M; Farde L
    J Neuroimaging; 1999 Oct; 9(4):217-22. PubMed ID: 10540601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D
    Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and disposition of vinpocetine in rats].
    Yao JH; Su CY; Chu XY
    Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced blood-brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider.
    Ding J; Sun Y; Li J; Wang H; Mao S
    J Drug Target; 2017 Jul; 25(6):532-540. PubMed ID: 28151022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
    Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
    Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
    Miskolczi P; Kozma K; Polgár M; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study.
    Wall A; Kågedal M; Bergström M; Jacobsson E; Nilsson D; Antoni G; Frändberg P; Gustavsson SA; Långström B; Yates R
    Drugs R D; 2005; 6(3):139-47. PubMed ID: 15869317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
    Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
    Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the absorption of vinpocetine and apovincaminic acid.
    Pudleiner P; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
    Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
    J Neuroimaging; 1998 Oct; 8(4):197-204. PubMed ID: 9780850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration.
    Ma Q; Dai M; Zhang H; Bai L; He N
    Xenobiotica; 2020 May; 50(5):580-587. PubMed ID: 31424307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
    Brain Res Bull; 2000 Oct; 53(3):245-54. PubMed ID: 11113577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.